Literature DB >> 32595765

Pragmatic Opioid Use in Painful Diabetic Neuropathy.

Yatan Pal Singh Balhara1, Shalini Singh2, Sanjay Kalra3.   

Abstract

The management of painful diabetic neuropathy poses a tough clinical challenge. Although opioid analgesics are considered as second- or third-line agents in the management of moderate-to-severe neuropathic pain, prescription of opioids for this indication is higher than expected. This narrative review is a recommendation on how to ensure pragmatic use of opioids for those with painful diabetic neuropathy while avoiding complications such as opioid overdose, opioid diversion and the development of opioid-use disorder. Risk mitigation strategies at the level of the clinician include periodic assessment and documentation of clinical details, treatment history and psychosocial status. Using a multimodal approach to pain management, medication counselling, adherence monitoring programmes, evidence-based opioid dosing strategies and empowering patients to make treatment decisions are effective strategies in reducing risk associated with prolonged opioid use. At the organisational and policy level, using prescription drug monitoring programmes, carrying out periodic opioid utilisation reviews and providing training to patients and physicians on safe opioid use are useful, implementable strategies. © Touch Medical Media 2020.

Entities:  

Keywords:  Diabetes; analgesia; neuropathy; opioid abuse; opioid addiction; opioids

Year:  2020        PMID: 32595765      PMCID: PMC7308105          DOI: 10.17925/EE.2020.16.1.21

Source DB:  PubMed          Journal:  Eur Endocrinol        ISSN: 1758-3772


  37 in total

Review 1.  Measuring health-related quality of life in diabetic peripheral neuropathy: a systematic review.

Authors:  S C Smith; D L Lamping; G D H Maclaine
Journal:  Diabetes Res Clin Pract       Date:  2011-12-10       Impact factor: 5.602

2.  Universal precautions: a matter of mutual trust and responsibility.

Authors:  Douglas Gourlay; Howard Heit
Journal:  Pain Med       Date:  2006 Mar-Apr       Impact factor: 3.750

3.  Prospective multicenter evaluation of tramadol exposure.

Authors:  H A Spiller; S E Gorman; D Villalobos; B E Benson; D R Ruskosky; M M Stancavage; D L Anderson
Journal:  J Toxicol Clin Toxicol       Date:  1997

Review 4.  Morphine for chronic neuropathic pain in adults.

Authors:  Tess E Cooper; Junqiao Chen; Philip J Wiffen; Sheena Derry; Daniel B Carr; Dominic Aldington; Peter Cole; R Andrew Moore
Journal:  Cochrane Database Syst Rev       Date:  2017-05-22

5.  Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the Opioid Risk Tool.

Authors:  Lynn R Webster; Rebecca M Webster
Journal:  Pain Med       Date:  2005 Nov-Dec       Impact factor: 3.750

6.  Neuropathic pain in diabetes, prediabetes and normal glucose tolerance: the MONICA/KORA Augsburg Surveys S2 and S3.

Authors:  Dan Ziegler; Wolfgang Rathmann; Thorsten Dickhaus; Christa Meisinger; Andreas Mielck
Journal:  Pain Med       Date:  2009-01-16       Impact factor: 3.750

7.  Tapentadol abuse potential: a postmarketing evaluation using a sample of individuals evaluated for substance abuse treatment.

Authors:  Stephen F Butler; Emily C McNaughton; Ryan A Black
Journal:  Pain Med       Date:  2014-09-22       Impact factor: 3.750

8.  Potential misuse and inappropriate prescription practices involving opioid analgesics.

Authors:  Ying Liu; Joseph E Logan; Leonard J Paulozzi; Kun Zhang; Christopher M Jones
Journal:  Am J Manag Care       Date:  2013-08       Impact factor: 2.229

Review 9.  Measures of adult pain: Visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain (NRS Pain), McGill Pain Questionnaire (MPQ), Short-Form McGill Pain Questionnaire (SF-MPQ), Chronic Pain Grade Scale (CPGS), Short Form-36 Bodily Pain Scale (SF-36 BPS), and Measure of Intermittent and Constant Osteoarthritis Pain (ICOAP).

Authors:  Gillian A Hawker; Samra Mian; Tetyana Kendzerska; Melissa French
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-11       Impact factor: 4.794

Review 10.  Tapentadol hydrochloride: A novel analgesic.

Authors:  Dewan Roshan Singh; Kusha Nag; Akshaya N Shetti; N Krishnaveni
Journal:  Saudi J Anaesth       Date:  2013-07
View more
  3 in total

Review 1.  Pathogenesis, diagnosis and clinical management of diabetic sensorimotor peripheral neuropathy.

Authors:  Gordon Sloan; Dinesh Selvarajah; Solomon Tesfaye
Journal:  Nat Rev Endocrinol       Date:  2021-05-28       Impact factor: 43.330

2.  First-in-Human Single-Ascending-Dose, Multiple-Dose, and Food Interaction Studies of NRD.E1, an Innovative Nonopioid Therapy for Painful Diabetic Peripheral Neuropathy.

Authors:  Eva Tiecke; Maurizio Rainisio; Theodor Guentert; Stephan Müller; Liat Hochman; Eli Kaplan; Sara Mangialaio
Journal:  Clin Pharmacol Drug Dev       Date:  2022-06-14

3.  Predicting the quality of life based on pain dimensions and psychiatric symptoms in patients with Painful diabetic neuropathy: a cross-sectional prevalence study in Iranian patients.

Authors:  Mohammadreza Davoudi; Parnian Rezaei; Fereshteh Rajaeiramsheh; Seyed Majid Ahmadi; Amir Abbas Taheri
Journal:  Health Qual Life Outcomes       Date:  2021-02-09       Impact factor: 3.186

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.